Skye Bioscience, Inc.

SKYE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $9.9M

Liabilities Breakdown FY2021

Total Liabilities: $4.0M